MedTrace Logo

Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

NCT01024478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 272

Last updated 2011-07-07

No results posted yet for this study

Summary

The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.

Conditions

Sponsors & Collaborators

  • Fujian Medical University Union Hospital

    collaborator OTHER

  • Air Force Military Medical University, China

    collaborator OTHER

  • Huazhong University of Science and Technology

    collaborator OTHER

  • Nanjing Medical University

    collaborator OTHER

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Capital Medical University

    lead OTHER

Principal Investigators

  • kuncheng li, M.D. · Xuanwu Hospital, Beijing

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01024478 on ClinicalTrials.gov